Tilray is a Canadian pharmaceutical company that is a global leader in cannabis research, cultivation, processing and distribution. It was founded in 2013 and has headquarters in Nanaimo, Vancouver, also operating in Latin America, Australia, New Zealand, Germany and Portugal. Tilray’s range of products include cannabis in the form of oil, flowers, edibles, vape pens and pre-rolls. The company owns a number of regional subsidiaries under the Tilray brand, as well as Manitoba Harvest and High Park Company. In 2021, Tilray merged with fellow cannabis company Aphria, creating a new entity for the duo. Tilray stock is dual-listed on the Nasdaq and Toronto stock exchanges. Start spread betting or trading CFDs on our Tilray share price.